• Science & Technology

First-in-human trial for new lung cancer immunotherapy

Cancer Research UK and VOLT, announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer Cancer Research UK and VOLT, announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer

17 December 2019

• Health & Medicine

Blood test can quickly match advanced breast cancer patients to targeted treatments

New trial results show that a blood test can identify rare types of advanced breast cancer and help patients to access the right treatment more quickly. New trial results show that a blood test can identify rare types of advanced breast cancer and help patients to access the right treatment more quickly.

12 December 2019

• Health & Medicine

Targeted ovarian cancer drug made available to more people on NHS in England

NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England. NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England.

11 December 2019

• Health & Medicine

Targeted ovarian cancer drug made more widely available on the NHS in Scotland

A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy. A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy.

9 December 2019

• Science & Technology

So-called 'junk DNA' affects inherited cancer risk

Research reveals how genetic variations in the regions of DNA that don't code for proteins, once dismissed as 'junk DNA', can affect a person's risk of cancer. Research reveals how genetic variations in the regions of DNA that don't code for proteins, once dismissed as 'junk DNA', can affect a person's risk of cancer.

6 December 2019

• Health & Medicine

A quarter of cancer patients experience avoidable delay to diagnosis

One in four cancer patients experienced a delay to their diagnosis that could have been avoided. One in four cancer patients experienced a delay to their diagnosis that could have been avoided.

4 December 2019

• Personal Stories

Young cancer survivor gets unforgettable festive treat as he meets the Snowman

Six-year-old Karos Rasoul from London gets a Christmas treat meeting the cast of Birmingham Repertory Theatre’s The Snowman at The Peacock, London. Six-year-old Karos Rasoul from London gets a Christmas treat meeting the cast of Birmingham Repertory Theatre’s The Snowman at The Peacock, London.

2 December 2019

• Health & Medicine

Bladder cancer treatment rejected for routine use on NHS in England


A treatment option for some people with bladder cancer, currently available through the CDF has been given an initial ‘no’ for routine use in England. 
A treatment option for some people with bladder cancer, currently available through the CDF has been given an initial ‘no’ for routine use in England.

26 November 2019

• Health & Medicine

Breast and kidney cancer drugs approved on NHS Scotland

Two new cancer treatment options have been accepted for use in Scotland for some patients living with breast and kidney cancer. Two new cancer treatment options have been accepted for use in Scotland for some patients living with breast and kidney cancer.

21 November 2019

• Science & Technology
• Health & Medicine

Blocking a survival mechanism could tackle melanoma treatment resistance

Researchers have demonstrated an approach which, used in parallel with existing treatments, wipes out the ‘survival system’ of cancer cells. Researchers have demonstrated an approach which, used in parallel with existing treatments, wipes out the ‘survival system’ of cancer cells.

14 November 2019